Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synbio TechROCO:1295 -0.40%44 Days Payable is 20.47 as of Dec. 2025, which is 15% below its 10-year median of 24.17. GuruFocus rates ROCO:1295 with a GF Score™ of 44/100. The stock has 10 warning signs investors should review. Among 701 Biotechnology companies, Synbio Tech ranks worse than 79.32% on this metric.
The historical rank and industry rank for Synbio Tech's Days Payable or its related term are showing as below:
ROCO:1295'
s Days Payable Range Over the Past 10 Years
Min: 23.48 Med: 24.17 Max: 32.09
Current: 32.09
During the past 6 years, Synbio Tech's highest Days Payable was 32.09. The lowest was 23.48. And the median was 24.17.
ROCO:1295's Days Payable is ranked worse than 79.32% of 701
companies
in the Biotechnology industry
Industry Median: 112.84
vs ROCO:1295: 32.09
Synbio Tech's Days Payable
declined
from Dec. 2024 (29.02) to Dec. 2025 (20.47).
It may suggest that Synbio Techaccelerated paying its suppliers.
Synbio Tech Days Payable Related Terms
Synbio Tech Days Payable Historical Data
* Premium members only.
The historical data trend for Synbio Tech's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:1295 vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Synbio Tech's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synbio Tech Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Synbio Tech's Days Payable distribution charts can be found below:
* The bar in red indicates where Synbio Tech's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Synbio Tech's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synbio Tech (ROCO:1295) has a Days Payable of 20.47 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Synbio Tech and its competitors. This is 15% below median its historical median of 24.17. Over the past decade, Synbio Tech's Days Payable has ranged from 23.48 to 32.09. According to the industry distribution chart, Synbio Tech ranks #556 out of 701 companies in the Biotechnology industry, placing it in the top 79.3%.
Is Synbio Tech's Days Payable too high?
Synbio Tech's current Days Payable of 20.47 is 15% below median its 10-year median of 24.17. Over the past 10 years, this metric has ranged from a low of 23.48 to a high of 32.09. The Biotechnology industry median Days Payable is 112.84. Synbio Tech's value of 20.47 is 81.9% below this industry median. Based on the distribution chart, Synbio Tech ranks #556 out of 701 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Synbio Tech has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Synbio Tech's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Synbio Tech ranks #556 out of 701 companies for Days Payable. This places Synbio Tech in the lower half of its industry. The industry median Days Payable is 112.84. Synbio Tech's value of 20.47 is 81.9% below this benchmark. Historically, Synbio Tech's own Days Payable has ranged from 23.48 to 32.09 over the past decade. While the company's 10-year median is 24.17 vs. the industry median of 112.84, Synbio Tech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.84, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Synbio Tech's current Days Payable of 20.47 is 81.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Synbio Tech and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synbio Tech's current Days Payable is 20.47, which is 15% below median its own 10-year median of 24.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synbio Tech stock overvalued right now?
Synbio Tech (ROCO:1295) has a current Days Payable of 20.47. The current Days Payable is 20.47, which is 15% below median its 10-year median of 24.17 and 81.9% below the Biotechnology industry median of 112.84. Synbio Tech's overall GF Score™ is 44/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Synbio Tech (ROCO:1295), the current Days Payable is 20.47 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Synbio Tech Inc focus on functional research and manufacturing of probiotics for human health and economic animals. It has two reportable segments, Taiwan and Mainland China Segment to engage in the production and R&D technologies of the Taiwan Segment, including the production and sales of concentrated fermentation liquid, lactobacillus plantarum solid drinks, and lactobacillus plantarum granules for animal husbandry. It generates majority of revenue from Taiwan segment includes production and sale of lactobacillus plantarum powder, lactobacillus plantarum fermentation derivative products, probiotics dietary supplements, probiotics products for pets and economic animals, and probiotics products. It has presence in Taiwan, China, Southeast Asia, and Others.
44GF Score
Get the complete analysis for ROCO:1295
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1295 has been successfully added to your 
